Similar Items: Perceived experiences of people with severe haemophilia A switching from factor VIII prophylaxis to emicizumab
- Severe haemophilia A with haemarthrosis improved on emicizumab: A case report
- Outcomes, challenges and prospects of emicizumab prophylaxis in Sub-Saharan Africa – Insights from the Tanzanian experience
- Clinical outcomes and safety profile of emicizumab and other treatment options for the management of children and adults with severe haemophilia A in the UAE: A retrospective study at two tertiary hospitals
- Lessons from a qualitative study of treatment experiences and perceptions in people with haemophilia in France
- Occult hepatitis B virus infection in people with haemophilia in South Africa
- Incidence and prevention of post-immunisation bleeding complications in people with haemophilia at a treatment centre in India